USPTO Patent Application for Dietary Supplement Formulation
Summary
The USPTO has published a patent application (US20260083814A1) for a dietary supplement formulation designed to alleviate sciatica pain and support nerve and musculoskeletal health. The application details a specific blend of natural ingredients and their purported benefits, filed on September 26, 2024.
What changed
The United States Patent and Trademark Office (USPTO) has published a new patent application, US20260083814A1, detailing a dietary supplement formulation. The application, filed on September 26, 2024, by Darius Jones, describes a specific blend of natural ingredients including Turmeric Extract, Myo-Inositol, MSM, Black Currant Extract, Omega 3 Fatty Acid, BioPerine, Magnesium, Vitamin D3, Vitamin B12, and Boswellia serrata Extract. The formulation is intended to alleviate sciatica pain, support nerve health, and enhance musculoskeletal health through anti-inflammatory, antioxidant, and neuroprotective properties.
This patent application represents a new disclosure in the area of therapeutic dietary supplements. While patent applications do not impose direct regulatory obligations on other entities, they signal innovation and potential future market entrants or product claims. Companies involved in the manufacturing or marketing of dietary supplements, particularly those targeting nerve health or inflammation, should be aware of this filing as it may indicate emerging trends or competitive intellectual property in the sector. No immediate compliance actions are required based solely on this patent application publication.
Source document (simplified)
DIETARY SUPPLEMENT FORMULATION AND METHOD OF PREPARATION THEREOF
Application US20260083814A1 Kind: A1 Mar 26, 2026
Inventors
Darius Jones
Abstract
The disclosure provides a dietary supplement formulation to alleviate sciatica pain, support nerve health, and enhance musculoskeletal health. The formula comprises a synergistic blend of natural ingredients, each selected for its specific properties. The formulation includes a Turmeric Extract (200 mg) for its anti-inflammatory and antioxidant effects, Myo-Inositol Powder (300 mg) for nerve signal transmission, MSM 80 Mesh (300 mg) for reducing inflammation and supporting connective tissue, and Black Currant Extract (250 mg) for its antioxidant properties. Omega 3 Fatty Acid (40 mg) provides anti-inflammatory and neuroprotective benefits, BioPerine (5 mg) enhances ingredient bioavailability, Magnesium (30 mg) supports nerve function and muscle relaxation, Vitamin D3 (10 mcg) is essential for bone health, Vitamin B12 (500 mcg) maintains healthy nerve cells, and Boswellia serrata Extract (100 mg) reduces inflammation.
CPC Classifications
A61K 36/9066 A61K 9/4833 A61K 31/047 A61K 31/10 A61K 31/12 A61K 31/202 A61K 31/4525 A61K 31/593 A61K 31/714 A61K 33/06 A61K 36/185 A61K 36/324 A61K 36/67 A61P 29/00
Filing Date
2024-09-26
Application No.
18896966
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: Patent Apps - Therapeutics (A61P) publishes new changes.